Traditional in vitro models often fall short in replicating the complexity of the human intestinal environment – limiting their ability to accurately assess transporter and enzyme function. Since the gut epithelium plays a central role in drug absorption and metabolism, reliable toxicity assessments of novel drugs are critical for guiding compound selection. To achieve this, more physiologically relevant in vitro gut models are needed.

In this webinar, explore how advanced organoid technology and cutting-edge readout platforms can transform preclinical evaluation of intestinal toxicity and drug metabolism.

You'll learn how MIMETAS’ OrganoReady® Colon Organoid model, combined with the Tecan Spark® Cyto multimode plate reader, enables quantification of transporter expression and function, supporting predictive preclinical evaluation of intestinal toxicity and drug metabolism.  

Webinar highlights:  

- Quantify transporter expression and function using the OrganoReady® Colon Organoid model.

- Gain morphological insights by combining excellent temporal resolution with high-resolution imaging on the Spark® Cyto multimode reader.

- Scale and standardize workflows with high-throughput, multiparametric readouts for reproducible preclinical evaluation.

Spark Cyto is for Research Use Only. Not for use in diagnostic procedures.

‍